Garmin Wearables Surge, Parsley Expands Coverage, FDA Targets GLP-1s

Garmin Wearables Surge, Parsley Expands Coverage, FDA Targets GLP-1s

From Fitt Insider by Joe Vennare

May 1, 2026 · 3 min

About this episode

This episode provides a quick overview of the latest health and wellness news, including Garmin's revenue growth, Parsley Health's nationwide coverage, and FDA's proposal on GLP-1s.

May 1, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Parsley Health goes in-network nationwide covering up to 150M Americans, moving functional and longevity care into reimbursement at scale FDA proposes excluding semaglutide and tirzepatide from bulk compounding lists, limiting 503B pharmacies' ability to produce lower-cost GLP-1 alternatives Garmin reports $1.75B Q1 revenue up 14% with fitness segment hitting $547M up 42%, now accounting for 31% of total revenue as largest division More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co

People in this episode

Host: Joe Vennare

Topics covered

  • health news
  • wellness
  • fitness
  • business updates
  • healthcare
  • reimbursement

Keywords

  • Garmin
  • Parsley Health
  • FDA
  • GLP-1
  • health news
  • fitness revenue
  • healthcare reimbursement

Mentioned in this episode

Organizations: Garmin, Parsley Health, FDA

Products: semaglutide, tirzepatide

More episodes of Fitt Insider

Explore listener stats, chart rankings, contacts and more on the Fitt Insider podcast page.